Traders should not interpret this as negative insider sentiment — the sale is mandatory and tax-related. No additional insider selling should be expected from this filing beyond the reported amount.
Price Chart
Executive Summary
Jonathan Gillis, an officer of MapLight Therapeutics, filed a Form 144 to notify intent to sell up to 4,000 shares of common stock, valued at approximately $108 million, solely to cover tax obligations upon vesting of restricted stock units. The sale is routine and tied to equity compensation settlement.
Key Facts
- Jonathan Gillis, an officer, intends to sell up to 4,000 shares of MapLight common stock.
- The shares are being sold solely to satisfy tax-withholding obligations upon vesting of restricted stock units.
- The transaction is not a discretionary sale but a standard practice following RSU settlement.
- Total value of shares subject to sale is approximately $108 million (based on $27,020 per share implied by 4,000 shares totaling $108,080,000).
- Filing date is April 15, 2026, with no indication of unusual timing relative to company catalysts.
Financial Impact
Approximately $108 million in shares may be sold, but only to cover tax liabilities from RSU vesting, not for personal gain.
Risk Factors
- Misinterpretation by retail investors as discretionary insider selling, potentially triggering short-term selling pressure.
- High dollar value per share suggests volatility risk if execution is not carefully managed.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001193125-26-157249 |
| Document: 0001193125-26-157249-index.html | 0001193125-26-157249 |
| Document: 0001193125-26-157249.txt | 0001193125-26-157249 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 10d ago | Insider Cluster | $8.00 | awaiting T+20 | — | $7.66 (+4.25%) |
Oct 15, 2026 11d ago | 144 | $7.70 | awaiting T+20 | — | $7.66 (−0.52%) |
Oct 15, 2026 11d ago | 144 | $7.70 | awaiting T+20 | — | $7.66 (−0.52%) |
Oct 15, 2026 11d ago | 144 | $7.70 | awaiting T+20 | — | $7.66 (−0.52%) |
Sep 24, 2026 4w ago | EFFECT | $10.76 $8.25 | ▼ −23.33% | ▼ −22.91% | $7.66 (−28.81%) |
Sep 18, 2026 5w ago | S-1/A | $10.90 $8.00 | ▼ −26.61% | ▼ −25.70% | $7.66 (−29.72%) |
Aug 4, 2026 11w ago | Insider Cluster | $12.92 $13.06 | ▲ +1.08% | ▲ +1.69% | $7.66 (−40.71%) |
Aug 3, 2026 12w ago | 144 | $12.94 $13.31 | ▲ +2.86% | ▲ +4.10% | $7.66 (−40.80%) |
Jul 30, 2026 12w ago | 144 | $13.02 $12.60 | ▲ +3.23% | ▲ +6.21% | $7.66 (+41.17%) |
Jul 28, 2026 12w ago | Insider Buy | $15.02 $12.86 | ▼ −14.38% | ▼ −19.40% | $7.66 (−49.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers